Bili, Rahma .
HRN: 24-82-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2024
CEFUROXIME 500MG (TAB)
03/24/2024
03/30/2024
PO
500mg
BID X 7 Days
S/P Primary LSTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes